The global market for Intracranial Stents was estimated at US$427.5 Million in 2024 and is projected to reach US$883.3 Million by 2030, growing at a CAGR of 12.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Intracranial Stents market.
The potential of intracranial stents is being further explored through innovations such as drug-eluting stents (DES), which have been successful in coronary artery disease treatments by reducing in-stent stenosis. The application of DES in treating intracranial atherosclerosis holds promise, necessitating further studies to fully evaluate their benefits and risks in larger patient groups and over longer periods. Moreover, ongoing advancements in stenting technology and techniques continue to enhance the safety and effectiveness of these interventions in managing ICAS. The exploration of new stenting technologies and procedural advancements are crucial to improving outcomes and expanding the applicability of intracranial stents in clinical settings.
The growth in the intracranial stents market is driven by several key factors. The increasing prevalence of conditions like intracranial aneurysms and strokes catalyzes the demand for effective stenting solutions. Technological advancements in stent design and materials, coupled with a growing aging population at risk for cerebrovascular diseases, further stimulate this demand. Supportive government policies and rising healthcare expenditures globally also contribute to the adoption of advanced medical treatments like intracranial stenting. Additionally, the rising popularity of minimally invasive procedures, improved diagnostic techniques, and expansions in healthcare infrastructure support the broader use of intracranial stents. Partnerships between hospitals, academic institutions, and device manufacturers, along with favorable insurance and reimbursement policies, are crucial in driving innovation and facilitating the accessibility of these critical treatments. Together, these factors underscore the dynamic growth and vital role of intracranial stents in contemporary medical practice, addressing complex neurological conditions effectively.
Intracranial Stents- Key Trends and Drivers Summarized
Intracranial stenting has become an essential treatment for intracranial atherosclerotic stenosis (ICAS), a major cause of stroke, particularly in Asian populations. Despite various treatment strategies including surgery and medication, endovascular treatments like stenting have gained prominence. However, comparative studies such as the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial suggest that while stenting is effective in certain scenarios, it does not universally outperform medical management. The trials indicate that stenting may be particularly beneficial for patients with specific types of strokes and those who have high recurrent stroke rates due to conditions like impaired collateral flow. The technology faces challenges, including regulatory restrictions on patient selection and the management of periprocedural risks such as unstable plaque and hyperperfusion, which are significant in determining the timing and success of stenting procedures.The potential of intracranial stents is being further explored through innovations such as drug-eluting stents (DES), which have been successful in coronary artery disease treatments by reducing in-stent stenosis. The application of DES in treating intracranial atherosclerosis holds promise, necessitating further studies to fully evaluate their benefits and risks in larger patient groups and over longer periods. Moreover, ongoing advancements in stenting technology and techniques continue to enhance the safety and effectiveness of these interventions in managing ICAS. The exploration of new stenting technologies and procedural advancements are crucial to improving outcomes and expanding the applicability of intracranial stents in clinical settings.
The growth in the intracranial stents market is driven by several key factors. The increasing prevalence of conditions like intracranial aneurysms and strokes catalyzes the demand for effective stenting solutions. Technological advancements in stent design and materials, coupled with a growing aging population at risk for cerebrovascular diseases, further stimulate this demand. Supportive government policies and rising healthcare expenditures globally also contribute to the adoption of advanced medical treatments like intracranial stenting. Additionally, the rising popularity of minimally invasive procedures, improved diagnostic techniques, and expansions in healthcare infrastructure support the broader use of intracranial stents. Partnerships between hospitals, academic institutions, and device manufacturers, along with favorable insurance and reimbursement policies, are crucial in driving innovation and facilitating the accessibility of these critical treatments. Together, these factors underscore the dynamic growth and vital role of intracranial stents in contemporary medical practice, addressing complex neurological conditions effectively.
Scope of Study:
The report analyzes the Intracranial Stents market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Product Type (Self-Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization); Indication (Brain Aneurysm, Intracranial Stenosis); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Self-Expanding Stents segment, which is expected to reach US$594.0 Million by 2030 with a CAGR of a 13.9%. The Balloon Expanding Stents segment is also set to grow at 11.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $113.8 Million in 2024, and China, forecasted to grow at an impressive 17.8% CAGR to reach $207.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Intracranial Stents Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Intracranial Stents Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Intracranial Stents Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Boston Scientific Corporation, Cook Medical, Inc., Johnson & Johnson, Medtronic PLC, Penumbra, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 14 companies featured in this Intracranial Stents market report include:
- Boston Scientific Corporation
- Cook Medical, Inc.
- Johnson & Johnson
- Medtronic PLC
- Penumbra, Inc.
- Stryker Corporation
- Terumo Corporation
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corporation
- Cook Medical, Inc.
- Johnson & Johnson
- Medtronic PLC
- Penumbra, Inc.
- Stryker Corporation
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 153 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 427.5 Million |
| Forecasted Market Value ( USD | $ 883.3 Million |
| Compound Annual Growth Rate | 12.9% |
| Regions Covered | Global |
